Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02581930
Title Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

skin melanoma

Therapies

Ibrutinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles County-USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field